Benchmark Investment Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.83M Sell
20,378
-211
-1% -$64.1K 3.87% 6
2026
Q1
$4.4M Buy
+20,589
New +$4.6M 2.56% 8
2025
Q3
$2.81M Buy
+20,972
New +$2.22M 1.63% 20
2025
Q1
$685K Sell
9,426
-8,330
-47% -$656K 0.44% 53
2024
Q4
$1.28M Sell
17,756
-15,254
-46% -$1.16M 0.83% 33
2024
Q3
$2.69M Buy
33,010
+400
+1% +$34.8K 1.92% 13
2024
Q2
$3.47M Buy
32,610
+3,220
+11% +$309K 2.51% 7
2024
Q1
$2.86M Buy
29,390
+1,590
+6% +$140K 2.25% 8
2023
Q4
$2.18M Sell
27,800
-210
-0.7% -$14.3K 2.02% 14
2023
Q3
$1.76M Buy
28,010
+2,680
+11% +$176K 1.77% 18
2023
Q2
$1.63M Buy
25,330
+5,100
+25% +$287K 1.5% 23
2023
Q1
$1.07M Sell
20,230
-400
-2% -$19.6K 1.1% 31
2022
Q4
$867K Sell
20,630
-750
-4% -$31.4K 0.92% 37
2022
Q3
$782K Sell
21,380
-2,660
-11% -$118K 0.84% 40
2022
Q2
$1.02M Buy
24,040
+5,870
+32% +$279K 1.07% 31
2022
Q1
$977K Buy
18,170
+2,490
+16% +$145K 0.73% 37
2021
Q4
$1.13M Buy
+15,680
New +$983K 0.93% 36

Other funds holding LRCX

Benchmark Investment Advisors's LRCX Position: Q2 2026 in Review

Benchmark Investment Advisors reduced its Lam Research (LRCX) stake by 1% in Q2 2026, selling an estimated $64.1K and leaving 20,378 shares worth $8.83M. The position accounts for 3.87% of the portfolio, ranked #6.

Benchmark Investment Advisors first reported a position in LRCX in Q4 2021 and has held it in 17 quarters since. 3,135 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Benchmark Investment Advisors held 20,378 shares of Lam Research worth $8.83M as of Q2 2026.
  • Benchmark Investment Advisors sold 211 Lam Research shares in Q2 2026, an estimated $64.1K.
  • Lam Research made up 3.87% of Benchmark Investment Advisors's portfolio in Q2 2026, its #6 holding.
  • Benchmark Investment Advisors first reported a position in Lam Research in Q4 2021 and has held it in 17 quarters since.
  • 3,135 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Benchmark Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.